Treating IBD: Biologics

Treating IBD: Biologics


(bright music) – [Announcer] Biologics are antibodies that target part of the
overactive immune system and can be delivered through injection or taken intravenously. Biologics are often used
for different forms of IBD at risk for progression to complications. Biologics may be recommended
from the start of your disease or considered later on
if you don’t respond to other therapies. It may take a few doses for patients to respond to biologics. However, some patients
take longer than others to see results. So talk to your doctor
about what to expect. The risks of biologics depend
on the proteins they target. Some may have an increased
risk of reactivating infections like tuberculosis or developing colds or a psoriasis-like skin condition. In some biologics, a very
small number of people, six in 10,000, may develop
non-Hodgkin’s lymphoma. The risks of untreated inflammation in IBD are higher than the risks
of these medications. So it’s important to control
the inflammation optimally. Always talk to your
doctor about your options and share the decision to
start a new medication. Learn more at
www.crohnscolitisfoundation.org.

Leave a Reply

Your email address will not be published. Required fields are marked *